-
Univercells Technologies and VectorBuilder Announce Strategic Partnership for Optimized Custom Viral Vector Production
PharmaSources
July 07, 2021
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has formed a worldwide strategic partnership with VectorBuilder, a global leader in vector design, optimization and manufacturin
-
Bharat Biotech Concludes Final Analysis for COVAXIN Efficacy from Phase 3 Clinical Trials
firstwordpharma
July 05, 2021
Bharat Biotech announced today safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a whole virion inactivated vaccine against SARS-CoV2, was developed in partnership with ICMR and NIV Pune.
-
JEDI launches billion molecules agains COVID19 challenge
pharmatimes
May 06, 2020
The Joint European Disruptive Initiative (JEDI) has launched a new initiative to bring together the world's scientists for a united attack against the novel coronavirus pandemic.
-
China shares epidemic control experience with over 100 countries: expert
chinadaily
March 25, 2020
China has shared with more than 100 countries its experience in the prevention and control of the novel coronavirus disease (COVID-19) epidemic as the world witnesses a growing number of infected cases of the disease, a Chinese epidemiology expert said he
-
SC Johnson Contributes $1 Million to CDC Foundation's Emergency Response Fund to Fight COVID-19
prnasia
March 14, 2020
As the global community continues its fight to contain the 2019 Novel Coronavirus (COVID-19) pandemic, SC Johnson today announced a $1 million contribution to the CDC Foundation's Emergency Response Fund to strengthen domestic and global public health inf